<p>Fluorescence probes offer a sensitive and selective approach for detecting arginine, a biomarker for various biological processes including cancer detection. This study presents a fluorescence turn-on sensor using Cu<sup>2+</sup>-quenched bovine serum albumin-derived carbon dots (BSA@CDs) for arginine detection. The synthesized CDs exhibited a strong blue fluorescence with a quantum yield of 10.15%. The sensing mechanism involved fluorescence quenching of BSA@CDs by Cu<sup>2+</sup> through static quenching mechanisms including electron transfer and Förster resonance energy transfer (FRET), followed by fluorescence recovery upon arginine binding. A linear correlation of <i>R</i><sup><i>2</i></sup> = 0.99 was observed, with a limit of detection (LOD) of 25.8&#xa0;µM. The method demonstrated high selectivity and stability against potential interfering biomolecules and ions. Furthermore, the developed BSA@CDs/Cu probe was applied to detect arginine in biological samples such as urine and saliva, achieving recovery rates ranging from 86 to 105% at different dilution factors. A paper-based assay using Whatman 40 filter paper was also developed as a proof of concept for potential point of care applications. This study highlights the potential of BSA@CDs/Cu as an efficient, economical, and non-intrusive fluorescent probe for arginine detection, paving the way for improved cancer biomarker screening methodologies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

BSA-Derived Carbon Dots for Turn-On Fluorescent Detection of Arginine in Biological Samples

  • Geneva Indongo,
  • Merin K. Abraham,
  • Greeshma Rajeevan,
  • Arathy B. Kala,
  • Dheyaa Mohammed Dhahir,
  • Sony George

摘要

Fluorescence probes offer a sensitive and selective approach for detecting arginine, a biomarker for various biological processes including cancer detection. This study presents a fluorescence turn-on sensor using Cu2+-quenched bovine serum albumin-derived carbon dots (BSA@CDs) for arginine detection. The synthesized CDs exhibited a strong blue fluorescence with a quantum yield of 10.15%. The sensing mechanism involved fluorescence quenching of BSA@CDs by Cu2+ through static quenching mechanisms including electron transfer and Förster resonance energy transfer (FRET), followed by fluorescence recovery upon arginine binding. A linear correlation of R2 = 0.99 was observed, with a limit of detection (LOD) of 25.8 µM. The method demonstrated high selectivity and stability against potential interfering biomolecules and ions. Furthermore, the developed BSA@CDs/Cu probe was applied to detect arginine in biological samples such as urine and saliva, achieving recovery rates ranging from 86 to 105% at different dilution factors. A paper-based assay using Whatman 40 filter paper was also developed as a proof of concept for potential point of care applications. This study highlights the potential of BSA@CDs/Cu as an efficient, economical, and non-intrusive fluorescent probe for arginine detection, paving the way for improved cancer biomarker screening methodologies.